One of the most important causes of neurological morbidity and mortality in the world is
ischemic stroke. It can be a result of multiple events such as embolism with a cardiac origin …

Stroke is currently one of the most common causes of death and disability in the world, and
its pathophysiology is a complex process, involving the oxidative stress and inflammatory …

Stroke is the second leading cause of death worldwide; however, the treatment choices
available to neurologists are limited in clinical practice. Lipocalin 2 (LCN2) is a secreted …

Post-stroke depression (PSD) affects approximately one-third of stroke survivors, severely
impacting general recovery and quality of life. Despite extensive studies, the exact …

Background: We aimed to identify plasma markers of unfavorable outcomes for patients with
acute ischemic stroke (AIS) after recanalization by endovascular thrombectomy (EVT) …

Acute ischemic stroke (AIS), is the second global cause of death after cardiovascular
diseases, accounts for 80–85% of cerebrovascular disease. Stroke diagnosis could be …

During a stroke, a series of biochemical and metabolic changes occur which eventually lead
to the death of cells by necrosis or apoptosis. This is a multi-stage process involving …

Ischemic stroke causes rapid hypoxic damage to the core neural tissue which is followed by
graded chronological tissue degeneration in the peri-infarct zone. The latter process is …

Background: Stroke is a leading cause of morbidity and mortality. Over the past decade,
plasma D-dimer levels have emerged as a biomarker for predicting stroke outcome …

Background: There is increasing evidence on the prognostic significance of D-dimer and
fibrinolysis in stroke. However, the systematic analysis of their relationship with adverse …